Rea developed the first at-home diagnostic test that tracks biochemical markers of preterm birth (PTB). Our solution allows doctors to continuously follow up pregnant women at risk of PTB to anticipate a potential early delivery.
Today, all of the medical examinations to monitor the risk of a PTB require invasive inspections of pregnant women. These tests have to be performed by a medical professional in a hospital, limiting significantly the number of pregnant women that can be tested.
Our technology could enable obstetricians to provide personalized prophylactic treatments to decrease neonatal mortalities and morbidities.
PTB is the leading cause of death among children <5 years of age &, every year, an estimated 15 million babies are born preterm.
Location: Switzerland, Vaud, Lausanne
Total raised: $1.6M
Investors 2
| Date | Name | Website |
| - | Venture Ki... | venturekic... |
| 22.10.2022 | VentureLab | venturelab... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.11.2020 | Pre-Seed | $1.6M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 22.01.2024 | DOPPL and Rea Diagnostics get FIT Funding Boost | DOPPL, organoids for the future of personalised medicine Using its unique data platform, its 'biobas... | startuptic... |
| 29.11.2023 | Swiss Delegation to Helsinki to demonstrate their innovation... | Every year, a delegation comprising Swiss startups and organisations heads to Helsinki to attend S... | startuptic... |
| 03.07.2023 | Swissnex San Francisco Propel Swiss Health Startups into the... | From June 19 to June 30, 2023, six Swiss startups travelled to San Francisco with their temporary ... | startuptic... |
| 19.10.2022 | Swiss startup solutions remain distinct worldwide | The Techstars physical health accelerator supports pulsewave Pulsewave is developing TempleGuard, ... | startuptic... |
| 04.05.2022 | Swiss entrepreneurs secure a spot in the Forbes 30 Under 30 ... | Honorees in Forbe’s latest 30 Under 30 Europe edition have collectively raised more than $2 billio... | startuptic... |